AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Stock indices represent aggregated price movements of selected groups of stocks, signaling market trends and sentiment for analysis.
16,340 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
In July, investors are weighing recession risks against reliable income. This guide highlights three dividend staples...
When inflation stays sticky, savvy investors look for AI stocks with durable cash flow and strong balance sheets. Her...
Two industry giants released mixed Q1 results, highlighting divergent paths for July. Lockheed Martin stays mission-f...
The hype around SpaceX often drowns out solid opportunities in AI-powered space companies. This guide shines a light ...
In 2026, JEPI remains a go-to for retirement income, yet Amplify DIVO is delivering stronger total returns for some i...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
Cathie Wood goes bargain isn’t a hype moment. It’s a disciplined approach to re-evaluating disrupted growth names aft...
As Shake Shack charts a path into 2025, investors seek clarity on margins, store growth, and digital momentum. This g...
In February 2026, Beyond Meat shares surged roughly 24%, propelled by optimism around product expansion and earnings ...
When a new Berkshire CEO speaks candidly about returns, investors sit up. This article digs into what 'greg abel call...
When CPSS releases its earnings, it can move the stock and shape investor sentiment for months. This guide breaks dow...